Fletcher Building Limited (FBU.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 5.18 |
| Open | 5.18 |
| Bid | 5.18 x 575900 |
| Ask | 5.19 x 611100 |
| Day's range | 5.14 - 5.24 |
| 52-week range | 5.14 - 7.64 |
| Volume | |
| Avg. volume | 1,171,014 |
| Market cap | 4.244B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 13.34 |
| EPS (TTM) | 0.39 |
| Earnings date | N/A |
| Forward dividend & yield | 0.34 (6.47%) |
| Ex-dividend date | 17 Mar 2022 |
| 1y target est | 8.13 |
- Simply Wall St.
Should You Investigate Fletcher Building Limited (NZSE:FBU) At NZ$6.15?
Fletcher Building Limited ( NZSE:FBU ), might not be a large cap stock, but it received a lot of attention from a...
- GlobeNewswire
Design Therapeutics Announces FDA Clearance of Investigational New Drug Application for First GeneTAC™ Molecule for Friedreich Ataxia
Phase 1 Trial of DT-216 in Patients with Friedreich Ataxia to Be Initiated Soon Topline Data from Phase 1 Trial Expected in the Second Half of 2022 CARLSBAD, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today announced that its Investigational New Drug Application (IND) for its lead candidate, DT-216, for the treatment of Friedreich ataxia (FA), was cleared by the U.S. Food an
- Simply Wall St.
What You Need To Know About Fletcher Building Limited's (NZSE:FBU) Investor Composition
The big shareholder groups in Fletcher Building Limited ( NZSE:FBU ) have power over the company. Institutions will...
© 2022 Yahoo. All rights reserved.
